IL126268A0 - Purification of plasmid dna of pharmaceutical quality - Google Patents
Purification of plasmid dna of pharmaceutical qualityInfo
- Publication number
- IL126268A0 IL126268A0 IL12626897A IL12626897A IL126268A0 IL 126268 A0 IL126268 A0 IL 126268A0 IL 12626897 A IL12626897 A IL 12626897A IL 12626897 A IL12626897 A IL 12626897A IL 126268 A0 IL126268 A0 IL 126268A0
- Authority
- IL
- Israel
- Prior art keywords
- purification
- plasmid dna
- pharmaceutical quality
- pharmaceutical
- quality
- Prior art date
Links
- 239000013612 plasmid Substances 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9603519A FR2746412B1 (fr) | 1996-03-21 | 1996-03-21 | Purification d'adn plasmidique de qualite pharmaceutique |
| PCT/FR1997/000472 WO1997035002A1 (fr) | 1996-03-21 | 1997-03-17 | Purification d'adn plasmidique de qualite pharmaceutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL126268A0 true IL126268A0 (en) | 1999-05-09 |
Family
ID=9490391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12626897A IL126268A0 (en) | 1996-03-21 | 1997-03-17 | Purification of plasmid dna of pharmaceutical quality |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6730781B1 (cs) |
| EP (1) | EP0902835A1 (cs) |
| JP (1) | JP2000506736A (cs) |
| KR (1) | KR100502116B1 (cs) |
| AU (1) | AU730755B2 (cs) |
| BR (1) | BR9708227A (cs) |
| CA (1) | CA2249465A1 (cs) |
| CZ (1) | CZ295587B6 (cs) |
| FR (1) | FR2746412B1 (cs) |
| HU (1) | HU225426B1 (cs) |
| IL (1) | IL126268A0 (cs) |
| NO (1) | NO984342L (cs) |
| SK (1) | SK129198A3 (cs) |
| WO (1) | WO1997035002A1 (cs) |
| ZA (1) | ZA972462B (cs) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7026468B2 (en) | 1996-07-19 | 2006-04-11 | Valentis, Inc. | Process and equipment for plasmid purification |
| US7807822B2 (en) | 1996-08-01 | 2010-10-05 | Robert Bridenbaugh | Methods for purifying nucleic acids |
| US6214586B1 (en) * | 1997-12-08 | 2001-04-10 | Genzyme Corporation | Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA |
| CZ303086B6 (cs) * | 2000-05-26 | 2012-03-28 | Aventis Pharma S.A. | Zpusob purifikace dvojretezcové DNA užitím imobilizovaného oligonukleotidu |
| FR2822476B1 (fr) * | 2001-03-23 | 2004-04-02 | Aventis Pharma Sa | Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice |
| WO2002077274A2 (fr) * | 2001-03-23 | 2002-10-03 | Gencell S.A. | Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice. |
| EP1554398A4 (en) | 2002-09-13 | 2005-12-14 | Valentis Inc | DEVICE AND METHOD FOR THE CLEANING OF NUCLEAR SULFUR IN THE PREPARATIVE SCALE |
| EP1628749B1 (en) | 2003-05-30 | 2019-07-31 | VGXI, Inc. | Devices and methods for biomaterial production |
| EP1664277B1 (en) * | 2003-09-17 | 2011-11-09 | Aventis Pharma S.A. | Method of preparation of pharmaceutically grade plasmid dna |
| AU2005233309B2 (en) * | 2004-04-19 | 2011-03-31 | Centelion | Method for purifying plasmid DNA |
| EP1737945B1 (en) * | 2004-04-19 | 2011-01-26 | Aventis Pharma S.A. | Method for purifying plasmid dna |
| AU2005280356B2 (en) | 2004-08-16 | 2008-09-25 | Clague P. Hodgson | Improved strains of E. coli for plasmid DNA production |
| CN101443452B (zh) | 2004-11-30 | 2013-03-27 | 梅瑞尔有限公司 | 用于细胞化学裂解的混合装置 |
| US20120258502A1 (en) * | 2011-04-08 | 2012-10-11 | Vinod Pandiripally | Method of producing recombinant plasmid dna using substantially solid growth medium |
| US20120283503A1 (en) * | 2011-04-29 | 2012-11-08 | The Johns Hopkins University | Nanoparticle loaded stem cells and their use in mri guided hyperthermia |
| CN116790578B (zh) * | 2023-08-22 | 2023-12-12 | 赛奥斯博生物科技(北京)有限公司 | 一种基于碱裂解法快速纯化质粒的生产工艺 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2691586B2 (ja) * | 1987-10-22 | 1997-12-17 | 旭光学工業株式会社 | 多孔質セラミックス及びその製法 |
| JPH01135792A (ja) * | 1987-11-20 | 1989-05-29 | Mitsui Toatsu Chem Inc | 核酸の分離・精製方法 |
| CA2006008C (en) * | 1988-12-20 | 2000-02-15 | Donald J. Kessler | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| JPH08505534A (ja) * | 1993-01-13 | 1996-06-18 | 森永乳業株式会社 | Ｍ−ｃｓｆ２２３の製造方法 |
| US5503816A (en) * | 1993-09-27 | 1996-04-02 | Becton Dickinson And Company | Silicate compounds for DNA purification |
| DE59507433D1 (de) * | 1994-02-07 | 2000-01-20 | Qiagen Gmbh | Verfahren zur herstellung endotoxinfreier oder an endotoxin abgereicherter nucleinsäuren und/oder oligonucleotide für die gentherapie |
| US5576196A (en) * | 1995-01-13 | 1996-11-19 | Vical Incorporated | Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth |
| ATE238321T1 (de) | 1996-02-06 | 2003-05-15 | Roche Diagnostics Gmbh | Verfahren zur herstellung von gereinigter nukleinsäure und deren verwendung |
-
1996
- 1996-03-21 FR FR9603519A patent/FR2746412B1/fr not_active Expired - Fee Related
-
1997
- 1997-03-17 HU HU9902152A patent/HU225426B1/hu not_active IP Right Cessation
- 1997-03-17 SK SK1291-98A patent/SK129198A3/sk unknown
- 1997-03-17 CA CA002249465A patent/CA2249465A1/fr not_active Abandoned
- 1997-03-17 EP EP97914411A patent/EP0902835A1/fr not_active Ceased
- 1997-03-17 IL IL12626897A patent/IL126268A0/xx unknown
- 1997-03-17 CZ CZ19982984A patent/CZ295587B6/cs not_active IP Right Cessation
- 1997-03-17 KR KR10-1998-0707410A patent/KR100502116B1/ko not_active Expired - Fee Related
- 1997-03-17 BR BR9708227A patent/BR9708227A/pt not_active Application Discontinuation
- 1997-03-17 AU AU21661/97A patent/AU730755B2/en not_active Ceased
- 1997-03-17 WO PCT/FR1997/000472 patent/WO1997035002A1/fr not_active Application Discontinuation
- 1997-03-17 JP JP9533199A patent/JP2000506736A/ja active Pending
- 1997-03-20 ZA ZA9702462A patent/ZA972462B/xx unknown
-
1998
- 1998-09-15 US US09/153,838 patent/US6730781B1/en not_active Expired - Fee Related
- 1998-09-18 NO NO984342A patent/NO984342L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000506736A (ja) | 2000-06-06 |
| HUP9902152A3 (en) | 2001-04-28 |
| ZA972462B (en) | 1997-09-29 |
| HUP9902152A2 (hu) | 1999-11-29 |
| NO984342D0 (no) | 1998-09-18 |
| AU2166197A (en) | 1997-10-10 |
| CZ295587B6 (cs) | 2005-08-17 |
| NO984342L (no) | 1998-09-18 |
| BR9708227A (pt) | 1999-07-27 |
| US6730781B1 (en) | 2004-05-04 |
| CA2249465A1 (fr) | 1997-09-25 |
| KR20000064693A (ko) | 2000-11-06 |
| WO1997035002A1 (fr) | 1997-09-25 |
| EP0902835A1 (fr) | 1999-03-24 |
| FR2746412A1 (fr) | 1997-09-26 |
| CZ298498A3 (cs) | 1999-01-13 |
| AU730755B2 (en) | 2001-03-15 |
| KR100502116B1 (ko) | 2005-12-20 |
| HU225426B1 (en) | 2006-11-28 |
| FR2746412B1 (fr) | 1998-06-12 |
| SK129198A3 (en) | 1999-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9626815D0 (en) | Method of sequencing DNA | |
| GB9620209D0 (en) | Method of sequencing DNA | |
| IL126268A0 (en) | Purification of plasmid dna of pharmaceutical quality | |
| GB9622500D0 (en) | Therapeutic gene | |
| AU3672797A (en) | Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides | |
| EP1027450A4 (en) | METHOD FOR DNA SHUFFLING | |
| ZA979996B (en) | Protein purification | |
| HUP9903947A3 (en) | Purification of neurotrophins | |
| GB9620769D0 (en) | Nucleic acid sequencing | |
| AU3796495A (en) | Purification apparatus | |
| GB9607066D0 (en) | Purification process | |
| EP1036159A4 (en) | METHOD FOR PURIFYING PLASMID DNA AND PLASMID DNA THAT IS SUBSTANTIALLY FREE OF GENOMIC DNA | |
| AU4314099A (en) | Novel method of large scale plasmid purification | |
| AUPO761697A0 (en) | Process for the purification of polyethers | |
| EP0517515A3 (en) | Method of purifying dna | |
| FR2753204B1 (fr) | Procede de preparation d'adn plasmidique | |
| AU6614198A (en) | Purification process | |
| HUP0003958A3 (en) | Process for preparation of 4-aryl-piperidines and intermediates | |
| PL335737A1 (en) | Caprolactam purification process | |
| AU3057399A (en) | Glass microfiber column and method for the preparation and purification of plasmid dna using the same | |
| AU4041997A (en) | Dna purification procedure | |
| GB2318350B (en) | Process for purification of hydrochlorofluoroethanes | |
| HUP9904173A3 (en) | Pharmaceutical composition for treating viral diseases | |
| GB9608376D0 (en) | Spinal column separation | |
| AU5512598A (en) | Matrix for rapid purification of nucleic acids |